3[1]Wooley BP, Urschel JD, Antkowiak JG, et al. Bronchogenic carcinoma in patients age 30 and younger[J]. Ann Thorac Cardiovasc Surg, 2000, 6(2): 86
4[2]Kuo CW, Chen YM, Chao JY, et al. Non-small cell lung cancer in very young and very old patients. Chest, 2000, 117(2):354～357Veness M J, Delaney G, Berry M. Lung cancer in patients aged 50 years and younger: clinical characteristics, treatment details and outcome[J]. Australas Radiol, 1999,43(3): 328
5[3]Sekine I, Nishiwaki Y, Yokose T, et al. Young lung cancer patients in Japan: different characteristics between the sexes[J]. Ann Thorac Surg ,1999,67(5):1451
6[4]Skarin AT, Herbst RS, Leong TL, et al. Lung cancer in patients under age 40[J]. Lung cancer, 2001, 32(3):255
7[5]Awadh-Behbehani N, Al-Humood K, Ayed A, et al. Comparison between young and old pateints with bronchogenic carcionma [J].Acta Oncol, 2000: 39(8): 995
8[6]McDuffie HH, Klassen DJ, Dosman JA, et al. Female-male differences in patients with primary lung cancer[J]. Cancer, 1987,59:1825
9[7]Nugent WC, Edney MT, Hammerness PG, et al .Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment[J]. Ann Thorac Surg ,1997,63:193～197
10[4]Arinaga M,Noguchi T,Takeno S,et al.Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma[J].Cancer,2003,97(2):457-464
